Logo image of BLNE

BEELINE HOLDINGS INC (BLNE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:BLNE - US2778025005 - Common Stock

2.05 USD
+0.23 (+12.64%)
Last: 11/28/2025, 8:14:44 PM
2.07 USD
+0.02 (+0.98%)
After Hours: 11/28/2025, 8:14:44 PM
Fundamental Rating

2

Overall BLNE gets a fundamental rating of 2 out of 10. We evaluated BLNE against 33 industry peers in the Beverages industry. Both the profitability and financial health of BLNE have multiple concerns. While showing a medium growth rate, BLNE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BLNE has reported negative net income.
BLNE had a negative operating cash flow in the past year.
BLNE had negative earnings in each of the past 5 years.
BLNE had a negative operating cash flow in each of the past 5 years.
BLNE Yearly Net Income VS EBIT VS OCF VS FCFBLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -38.45%, BLNE is doing worse than 87.88% of the companies in the same industry.
With a Return On Equity value of -48.27%, BLNE is not doing good in the industry: 87.88% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -38.45%
ROE -48.27%
ROIC N/A
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLNE Yearly ROA, ROE, ROICBLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

BLNE has a worse Gross Margin (27.70%) than 90.91% of its industry peers.
BLNE's Gross Margin has improved in the last couple of years.
BLNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
BLNE Yearly Profit, Operating, Gross MarginsBLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

3

2. Health

2.1 Basic Checks

BLNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
BLNE has more shares outstanding than it did 1 year ago.
BLNE has more shares outstanding than it did 5 years ago.
BLNE has a better debt/assets ratio than last year.
BLNE Yearly Shares OutstandingBLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K
BLNE Yearly Total Debt VS Total AssetsBLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -1.27, we must say that BLNE is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.27, BLNE is not doing good in the industry: 81.82% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.12 indicates that BLNE is not too dependend on debt financing.
BLNE has a better Debt to Equity ratio (0.12) than 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z -1.27
ROIC/WACCN/A
WACC6.75%
BLNE Yearly LT Debt VS Equity VS FCFBLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

BLNE has a Current Ratio of 1.22. This is a normal value and indicates that BLNE is financially healthy and should not expect problems in meeting its short term obligations.
BLNE has a Current ratio (1.22) which is in line with its industry peers.
A Quick Ratio of 1.22 indicates that BLNE should not have too much problems paying its short term obligations.
BLNE has a better Quick ratio (1.22) than 75.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
BLNE Yearly Current Assets VS Current LiabilitesBLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

4

3. Growth

3.1 Past

BLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.69%, which is quite impressive.
Looking at the last year, BLNE shows a very negative growth in Revenue. The Revenue has decreased by -29.13% in the last year.
Measured over the past years, BLNE shows a very negative growth in Revenue. The Revenue has been decreasing by -20.16% on average per year.
EPS 1Y (TTM)47.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.53%
Revenue 1Y (TTM)-29.13%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%41.08%

3.2 Future

Based on estimates for the next years, BLNE will show a very strong growth in Earnings Per Share. The EPS will grow by 41.96% on average per year.
The Revenue is expected to grow by 48.40% on average over the next years. This is a very strong growth
EPS Next Y-62.36%
EPS Next 2Y41.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-33.68%
Revenue Next 2Y48.4%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BLNE Yearly Revenue VS EstimatesBLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M 25M
BLNE Yearly EPS VS EstimatesBLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2022 2023 2024 2025 2026 0 -100 -200 -300

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BLNE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 50.25, the valuation of BLNE can be described as expensive.
66.67% of the companies in the same industry are cheaper than BLNE, based on the Price/Forward Earnings ratio.
BLNE is valuated rather expensively when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 50.25
BLNE Price Earnings VS Forward Price EarningsBLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLNE Per share dataBLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

A more expensive valuation may be justified as BLNE's earnings are expected to grow with 41.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.96%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BLNE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEELINE HOLDINGS INC

NASDAQ:BLNE (11/28/2025, 8:14:44 PM)

After market: 2.07 +0.02 (+0.98%)

2.05

+0.23 (+12.64%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)11-06 2025-11-06
Earnings (Next)04-13 2026-04-13/amc
Inst Owners2.44%
Inst Owner Change611.14%
Ins Owners11.65%
Ins Owner Change61.1%
Market Cap56.91M
Revenue(TTM)6.10M
Net Income(TTM)-26.36M
Analysts85.71
Price Target4.59 (123.9%)
Short Float %8.56%
Short Ratio0.9
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-28.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-33.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 50.25
P/S 6.6
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 2.45
EV/EBITDA N/A
EPS(TTM)-30.32
EYN/A
EPS(NY)0.04
Fwd EY1.99%
FCF(TTM)-0.4
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.31
BVpS2.78
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -38.45%
ROE -48.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.7%
FCFM N/A
ROA(3y)-45.89%
ROA(5y)-36.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y24.05%
GM growth 5Y5.13%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.65%
Cap/Sales 3.33%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z -1.27
F-Score5
WACC6.75%
ROIC/WACCN/A
Cap/Depr(3y)62.29%
Cap/Depr(5y)46.27%
Cap/Sales(3y)7.25%
Cap/Sales(5y)5.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.53%
EPS Next Y-62.36%
EPS Next 2Y41.96%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.13%
Revenue growth 3Y-32.73%
Revenue growth 5Y-20.16%
Sales Q2Q%41.08%
Revenue Next Year-33.68%
Revenue Next 2Y48.4%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-204.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-208.53%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-324.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-329.66%
OCF growth 3YN/A
OCF growth 5YN/A

BEELINE HOLDINGS INC / BLNE FAQ

What is the fundamental rating for BLNE stock?

ChartMill assigns a fundamental rating of 2 / 10 to BLNE.


Can you provide the valuation status for BEELINE HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to BEELINE HOLDINGS INC (BLNE). This can be considered as Overvalued.


Can you provide the profitability details for BEELINE HOLDINGS INC?

BEELINE HOLDINGS INC (BLNE) has a profitability rating of 1 / 10.


How financially healthy is BEELINE HOLDINGS INC?

The financial health rating of BEELINE HOLDINGS INC (BLNE) is 3 / 10.


Is the dividend of BEELINE HOLDINGS INC sustainable?

The dividend rating of BEELINE HOLDINGS INC (BLNE) is 0 / 10 and the dividend payout ratio is 0%.